During an interview on Fox & Friends on Friday, Stergiou said AI will play a major role in helping cure cancer by enabling ...
Drug development is among the slowest, most failure-prone processes in modern science, with about 90% of drug candidates ...
There are more than 30 types of muscular dystrophy and over 7,000 known mutations in the Duchenne gene alone, which has ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, /PRNewswire/ -- Harbour BioMed (the 'Company'; HKEX: 02142), a global biopharmaceutical company focused on the discovery and development of ...
Companies aim to improve drug discovery by training AI on one another’s data and generating large, open datasets ...
Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b ...
As generative AI captures public attention, a different kind of AI is reshaping drug discovery. Machine learning models are ...
Discover how AI-powered analytics and experimental validation combine to improve target identification and accelerate drug ...
Hong Kong-listed Insilico Medicine has cut drug development timelines to about one year by combining AI with its China research ecosystem, its CEO said, giving it an edge over traditional Western ...
A challenge to the government’s refusal to release an impact assessment of a controversial pharmaceutical trade deal with the ...
TAIZHOU CITY, ZHEJIANG, CHINA, July 22, 2026 /EINPresswire.com/ — On June 1, Haisco Pharmaceutical Group announced that its proprietary innovative intravenous anesthetic, Cipepofol Injection (CYPSEDO) ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today announced that the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results